CYNTHIA BAXTER: Open Payments
NPI 1033732276 · PALM COAST, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,347 in 41 payments from 13 companies in 2025. Trend: 2023 $2,342 · 2024 $738 · 2025 $1,347
Food & beverage: $1,347
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $593 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $146 |
| E.R. Squibb & Sons, L.L.C. | 3 | $138 |
| Axsome Therapeutics, Inc. | 3 | $87 |
| Tris Pharma Inc | 3 | $65 |
| Supernus Pharmaceuticals, Inc. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Lundbeck LLC | 2 | $55 |
| Corium, LLC | 3 | $51 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
Products named: VRAYLAR, CAPLYTA, COBENFY, REXULTI, Auvelity, Qelbree, Azstarys, Onyda XR.
Industry payments across FL — which companies pay providers there.
